ASH, the world's largest professional society concerned with the causes and treatments of blood disorders, regularly issues press releases highlighting clinical and research advances announced at the ASH annual meeting and published in Blood, as well as releases and statements on breaking policy news affecting the field of hematology.
News and Press Releases
ASH Names Editor-in-Chief of New Journal Blood Global Hematology
Apr. 16, 2024
Study Shows Feasibility of Ending Specialist Follow-Up in Patients with Low-Risk CLL
Apr. 04, 2024
MRI and Lumbar Puncture Not Necessarily Required to Manage CAR T-Cell Therapy Complications
Mar. 19, 2024
T-cell Malignancies Represent Small Fraction of the Reported Secondary Cancers following CAR-T in the FDA’s Adverse Event Reporting System
Mar. 14, 2024
ASH Statement on Introduction of Health Home Legislation for People Living with Sickle Cell Disease
Feb. 29, 2024
Combination Therapy Lowers Blood Pressure in Patients Receiving Ibrutinib
Feb. 5, 2024
American Society of Hematology Announces 2024 Scholar Award Recipients
Feb. 1, 2024
ASH Supports CMMI’s Cell & Gene Therapy Access Model for Sickle Cell Disease
Jan. 31, 2024
Obesity Linked to Detection of Blood Cancer Precursor
Jan. 12, 2024
Mohandas Narla, DSc, Begins Term as 2024 ASH President
Jan. 09, 2024
Liso-cel is a Cost Effective Second-line Treatment for Common Form of Lymphoma
Dec. 28, 2023
Study Finds That Severe Long-Term Complications of Pulmonary Embolism in Children Are Rare
Dec. 26, 2023
Study Suggests COVID-19 Vaccine Safe and Effective for Individuals with Sickle Cell Disease
Dec. 18, 2023
Revumenib Found Effective Against High-Risk KMT2Ar Acute Leukemia
Dec. 12, 2023
Modified Stem Cell Transplant Procedure Shows Favorable Results in Adults Living with Severe Sickle Cell Disease
Dec. 12, 2023
Ibrutinib-Venetoclax Combination Found Effective Against Mantle Cell Lymphoma
Dec. 12, 2023
Daratumumab Plus Bortezomib, Lenalidomide, and Dexamethasone (VRd) Outperforms VRd Alone for Multiple Myeloma
Dec. 12, 2023
ASH Recognizes Senator Chris Van Hollen with 2023 Public Service Award
Dec. 11, 2023
Studies Highlight Both Novel Treatments and Enduring Value of Older Approaches
Dec. 10, 2023
Research Reveals Opportunities to Better Address Blood Disorders Early in Life
Dec. 09, 2023
Studies Highlight Impacts of Applying New Technologies in Everyday Care
Dec. 09, 2023
Studies Uncover Drivers of Health Disparities and Opportunities to Enhance Equity
Dec. 09, 2023
ASH Statement on FDA’s Approval of New Sickle Cell Disease Gene Therapy
Dec. 08, 2023
ASH to Recognize Guideline Implementation Champions at 65th Annual Meeting
Dec. 07, 2023
The American Society of Hematology Honors Dr. Elaine Muchmore with the 2023 Exemplary Service Award
Dec. 06, 2023
Blood Clotting Risk Quickly Drops After Stopping Hormonal Contraceptives
Nov. 08, 2023
Individuals with Severe Sickle Cell Disease Express High Risk Tolerance for Gene Therapies
Oct. 31, 2023
New Leadership Elected to the American Society of Hematology
Oct. 26, 2023
CAR T Cell Therapy Effective in Patients with Blood Cancer Regardless of Race
Oct. 19, 2023
ASH Recognizes 2023 Choosing Wisely Champions
Oct. 2, 2023
Pneumococcal Vaccines Linked with Fewer Severe Infections Among Children with Sickle Cell Disease
Sep. 12, 2023
ASH Names Editors-in-Chief of New Blood Journals
Sep. 8, 2023
Patients with AML Who Received Vitamin C/D Supplements Had Fewer Complications, But No Overall Survival Benefit Seen
Sep. 6, 2023
ASH Announces New ASH-AMFDP Hematology Scholars
Aug. 23, 2023
First-of-its-Kind Study Reveals Predictive Factors for Outcomes of AdvancedStage AL Amyloidosis
Aug. 15, 2023
Obesity and High Weight Linked to Adverse Outcomes in Leukemia Treatment
Jul. 11, 2023
ASH Advocates for Diversity in Medicine
Jun. 30, 2023
ASH Announces the 2023 Honorific Award Recipients
Jun. 28, 2023
Study Uncovers Direct Link Between Blood Group A and a Higher Risk for COVID-19 Infection
Jun. 27, 2023
New Data Informs Treatment of Blood Cancer During Pregnancy
Jun. 1, 2023
Statement on New ASH Clinical Practice Guidelines on Thrombophilia
May 17, 2023
Extreme Poverty a Key Driver for Relapse in Kids With ALL
Apr. 18, 2023
A Promising Outlook: CAR T Cells Improve Patient Quality of Life
Mar. 30, 2023
ASH President Commends Reintroduction of Sickle Cell Disease Medicaid Demonstration Program
Mar. 22, 2023
Quantifying the Life Expectancy Gap for People Living with Sickle Cell Disease
Mar. 16, 2023
Protect Medical Research
Urge your members of Congress to support continued medical research funding.